Evidence map›Paper›PMID 28011624›Full record

ArticleCancer research2017

Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women.

Joshua N Sampson, Roni T Falk, Catherine Schairer, Steven C Moore, Barbara J Fuhrman, Cher M Dallal, Douglas C Bauer, Joanne F Dorgan, Xiao-Ou Shu, Wei Zheng and 6 more

Open access · greenAbstract read
In one paragraph

Article in Cancer research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 2 pooled it
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 2 syntheses or guidelines pooled it, 123 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Bufalin Inhibits the PI3K/AKT Pathway by Targeting GTF3C4 to Impede Breast Cancer Progression.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Air Pollutants in Puerto Rico: Key Pollutants and Carcinogenic Properties.International journal of environmental research and public health · 2025
    Review
  11. Review
  12. Circulating Estrogen Metabolites and Risk of Breast Cancer among Postmenopausal Women in the Nurses' Health Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  13. Estrogens and breast cancer.Annals of oncology : official journal of the European Society for Medical Oncology · 2025
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Joshua N SampsonDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland. gierachg@mail.nih.gov sampsonjn@mail.nih.gov.
Roni T FalkDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Catherine SchairerDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Steven C MooreDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Barbara J FuhrmanUniversity of Arkansas for Medical Sciences, Fay W. Boozman College of Public Health, Little Rock, Arkansas.
Cher M DallalUniversity of Maryland School of Public Health, College Park, Maryland.
Douglas C BauerUniversity of California at San Francisco, San Francisco, California.
Joanne F DorganUniversity of Maryland School of Medicine, Baltimore, Maryland.
Xiao-Ou ShuVanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
Wei ZhengVanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
Louise A BrintonDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Mitchell H GailDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Regina G ZieglerDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Xia XuFrederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland.
Robert N HooverDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Gretchen L GierachDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland. gierachg@mail.nih.gov sampsonjn@mail.nih.gov.
University of California, San Francisco · US

Funding

Hormone-Related CancersZIACP010126 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI GIERACH, GRETCHEN · 2009 to 2025
$103.5M
Shanghai Womens Health StudyUM1CA182910 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ZHENG, WEI · 2014 to 2018
$5.9M
Cancer Risk Reduction and Diet: A Cohort Study of WomenR37CA070867 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ZHENG, WEI · 2009 to 2013
$4.7M
CCR NIH HHS HHSN261200800001CIntramural NIH HHS ZIA CP010126NCI NIH HHS HHSN261200800001ENCI NIH HHS R37 CA070867NCI NIH HHS UM1 CA182910
6 · The paper itself

Abstract

Endogenous estradiol and estrone are linked causally to increased risks of breast cancer. In this study, we evaluated multiple competing hypotheses for how metabolism of these parent estrogens may influence risk. Prediagnostic concentrations of estradiol, estrone, and 13 metabolites were measured in 1,298 postmenopausal cases of breast cancer and 1,524 matched controls in four separate patient cohorts. The median time between sample collection and diagnosis was 4.4 to 12.7 years across the cohorts. Estrogen analytes were measured in serum or urine by liquid chromatography-tandem mass spectrometry. Total estrogen levels (summing all 15 estrogens/estrogen metabolites) were associated strongly and positively with breast cancer risk. Normalizing total estrogen levels, we also found that a relative increase in levels of 2-hydroxylation pathway metabolites, or in the ratio of 2-hydroxylation:16-hydroxylation pathway metabolites, were associated inversely with breast cancer risk. These associations varied by total estrogen levels, with the largest risk reductions occurring in women in the highest tertile. With appropriate validation, these findings suggest opportunities for breast cancer prevention by modifying individual estrogen metabolism profiles through either lifestyle alterations or chemopreventive strategies.

Indexed as

AdultAgedBreast NeoplasmsChromatography, LiquidCohort StudiesEstrogensFemaleHumansHydroxylationMiddle AgedPostmenopauseRiskTandem Mass SpectrometryEstrogens

Identifiers

PMID28011624
PMCPMC5313342
OpenAlexW2562984926

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.